Bruno J. Battistini

Bruno J. Battistini's work experience includes serving as the Committee Chair for the Canada Foundation for Innovation/Fondation canadienne pour l'innovation, overseeing scientific and technical merit review committees for biomedical research and biosciences infrastructure funds. Bruno J. was also the National Executive Director and COO for RI-MUHC, leading initiatives in clinical trials and training platforms. Additionally, they held roles as the Chief Clinical and Governmental Affairs Officer at Pulmonem Inc., Adjunct Professor at the University of Ottawa, and a member of the Board of Directors and Scientific & e-Health Advisory Board at ServUs Health. Bruno J. has also chaired the FACS-ROC committee at CQDM, served as a Lecturer at the Université de Sherbrooke, and been a member of various research and strategic working groups. Bruno's expertise includes toxicology and medical advisory roles at Charles River Laboratories and MedX Health Corp.

Bruno J. Battistini's education history includes a post-doctoral fellowship in Cardiovascular Science at Université de Sherbrooke from 1996 to 1997, a post-doctoral fellowship in Pharmacology at The University of British Columbia from 1995 to 1996, and a postdoctoral fellowship in Health Research (cardiology-cardiovascular, pulmonary-respirology) at The William Harvey Research Institute from 1992 to 1995. Bruno J. also obtained a Ph.D. in Pharmacology from Université de Sherbrooke from 1989 to 1992, an M.Sc. in Biology from Université de Sherbrooke from 1987 to 1989, and a B.Sc. in Cellular Physiology from Université de Sherbrooke from 1984 to 1987.